Innate immunity response in Anti-systemic Candida albicans infection

Abstract

Abstract: Candida albicans is a common pathogen which may induce superficial and deep infection of human.It is believed that innate immune response plays a leading role in the host anti-systemic infection of Candida albicans.Innate immune response mediating anti-Candida infection comprises a range of fungal recognition receptors and immune effector cells. Host immune response to systemic Candida albicans infection is critical for the prognosis of patients.In this paper,the mechanism of innate immune response in host anti-systemic Candida albicans infection was summarized.

Key words: Candida albicans, systemic infection, innate immune response

CLC Number:

R379.4

CHEN Xia, CUI Fan, LIN Zhao-chun. Innate immunity response in Anti-systemic Candida albicans infection[J]. Chinese Journal of Mycology, 2014, 9(1): 52-55,59.

References

[1] Netea MG, Brown GD, Kullberg BJ, et al.An integrated model of the recognition of Candida albicans by the innate immune system[J]. Nat Rev Microbiol, 2008, 6(1):67-78.
[2] Vonk AG, Netea MG, Tos WM van der Meer, et al.Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy[J].Expert Opin Biol Ther, 2006, 6(9):891-903.
[3] Gauglitz G, Callenberg H, Weind G, et al.Host Defence Against Candida albicans and the Role of Pattern recognition Receptors[J].Acta Derm Venereol, 2012, 92(3):291-298.
[4] Gil ML, Gozalbo D.Role of Toll-like receptors in systemic Candida albicans infections[J]. Front Biosci, 2009, 14:570-582.
[5] Gozalbo D, Gil ML.IFN-γ in Candida albicans infections[J]. Front Biosci, 2009, 14:1970-1978.
[6] Netea MG, Van der Graaf CA, Vonk AG, et al.The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis[J].J Infect Dis, 2002, 185(10):1483-1489.
[7] Van der Graaf CA, Netea MG, Verschueren I, et al.Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae[J].Infect Immun, 2005, 73(11):7458-7464.
[8] Villamon E, Gozalbo D, Roig P, O'Connor JE, et al.Toll-likereceptor-2 is essential in murine defenses against Candida albicans infections[J].Microbes Infect, 2004, 6(1):1-7.
[9] Blasi E, Mucci A, Neglia R, et al.Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans[J]. FEMS Immunol Med Microbiol, 2005, 44(1):69-79.
[10] Netea MG, Sutmuller R, Hermann C.et al.Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells[J]. J Immunol, 2004, 172(6):3712-3718.
[11] Netea MG, van der Meer JWM, Sutmuller RP, et al.From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias[J].Antimicrob Agents Chemother, 2005, 49(10):3991-3996.
[12] Murciano C, Villamon E, Gozalbo D, et al.Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection[J]. Med Mycol, 2006, 44(2):149-157.
[13] Netea MG, Gow NA, Joosten LA, et al.Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors[J]. Med Mycol, 2010, 48(7):897-903.
[14] Netea MG, Gow NA Munro CA, Bates S, et al.Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors[J].J Clin Invest, 2006, 116(6): 1642-1650.
[15] Heinsbroek SE, Taylor PR, Martinez FO, et al.Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis[J].PLoS Pathog, 2008, 4(11):e1000218.
[16] LeibundGut-Landmann S, Gross O, Robinson MJ, et al.Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17[J].Nat Immunol, 2007, 8(6):630-638.
[17] Gale's A, Conduche A, Bernad J, et al.PPARc Controls Dectin-1 Expression Required for Host Defense against Candida albicans[J].PLoS Pathog, 2010, 6(1):e1000714.
[18] Taylor PR, Tsoni SV, Willment JA, et al.Dectin-1 is required for beta-glucan recognition and control of fungal infection[J].Nat Immunol, 2007, 8(1):31-38.
[19] Gross O, Gewies A, Finger K, et al.Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity[J].Nature, 2006, 442(7103):651-656.
[20] Heinsbroek SE, Brown GD, Gordon S.Dectin-1 escape by fungal dimorphism[J].Trends Immunol, 2005, 26(7):352-354.
[21] Wheeler RT, Kombe D, Agarwala SD, et al.Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment[J].PLoS Pathog, 2008, 4(12):e1000227.
[22] Sato K,Yang XL,Yudate T,et al.Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor gamma chain to induce innate immune responses[J].J Biol Chem,2006,281(50):38854-38866.
[23] Koppel EA, van Gisbergen KP, Geijtenbeek TB,et al.Distinct functions of DC-SIGN and its homologues L-SIGN(DC-SIGNR) and mSIGN1 in pathogen recognition and immune regulation[J].Cell Microbiol,2005,7(2):157-165.
[24] Cambi A,Netea MG,Mora-Montes HM,et al.Dendritic cell interaction with Candida albicans critically depends on N-linked mannan[J].J Biol Chem,2008,283(29):20590-20599.
[25] Bugarcic A,Hitchens K,Beckhouse AG,et al.Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans[J].Glycobiology,2008,18(9):679-685.
[26] Wells CA,Salvage-Jones JA,Li X,et al.The macrophage-inducible C-type lectin,mincle, is an essential component of the innate immune response to Candida albicans[J].J Immunol,2008,180(11):7404-7413.
[27] Ashman RB.Protective and pathologic immune responses against Candida albicans infection[J]. Front Biosci,2008,13:3334-3351.
[28] Richardson M,Rautemaa R.How the host fights against Candida infections[J]. Front Biosci,2009,14:4363-4375.
[29] Quintin J,Saeed S,Martens JHA,et al.Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. [J]. Cell Host Microbe,2012,12(2):223-232.
[30] Brown GD. Innate antifungal immunity: the key role of phagocytes [J].Annu Rev Immunol,2011,29: 1-21.
[31] Vylkova S,Sun JN,Edgerton M.The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides[J].Purinergic Signal,2007,3(1-2):91-97.
[32] Ortega E,Algarra I,Serrano MJ,et al.Enhanced resistance to experimental systemic candidiasis in tilorone-treated mice[J]. FEMS Immunol Med Microbiol,2000,28(4):283-289.
[33] Balish E,Warner T,Pierson CJ,et al.Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects[J].Med Mycol,2001,39(3):261-268.
[34] Ramirez-Ortiz ZG,Means TK.The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C.albicans)[J].Virulence,2012,3(7):635-646.
[35] d'Ostiani CF,Del SG,Bacci A,et al.Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans.Implications for initiation of T helper cell immunity in vitro and in vivo[J].J Exp Med,2000,191(10):1661-1674.
[36] Romagnoli G,Nisini R,Chiani P,et al.The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and acquisition of a Th1 response-promoting function[J]. J Leukoc Biol,2004,75(1):117-126.